FI850759L - Steroidfoerening. - Google Patents

Steroidfoerening.

Info

Publication number
FI850759L
FI850759L FI850759A FI850759A FI850759L FI 850759 L FI850759 L FI 850759L FI 850759 A FI850759 A FI 850759A FI 850759 A FI850759 A FI 850759A FI 850759 L FI850759 L FI 850759L
Authority
FI
Finland
Prior art keywords
compound
chem
therapy
formula
treatment
Prior art date
Application number
FI850759A
Other languages
English (en)
Finnish (fi)
Other versions
FI850759A0 (fi
FI850759A7 (fi
Inventor
William Edward Jones
Roderic Stafford Andrews
Original Assignee
Sterwin Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin Ag filed Critical Sterwin Ag
Publication of FI850759A0 publication Critical patent/FI850759A0/fi
Publication of FI850759L publication Critical patent/FI850759L/fi
Publication of FI850759A7 publication Critical patent/FI850759A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI850759A 1984-02-25 1985-02-25 Steroidiyhdiste. FI850759A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848404980A GB8404980D0 (en) 1984-02-25 1984-02-25 Steroid compound

Publications (3)

Publication Number Publication Date
FI850759A0 FI850759A0 (fi) 1985-02-25
FI850759L true FI850759L (fi) 1985-08-26
FI850759A7 FI850759A7 (fi) 1985-08-26

Family

ID=10557191

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850759A FI850759A7 (fi) 1984-02-25 1985-02-25 Steroidiyhdiste.

Country Status (13)

Country Link
EP (1) EP0154476B1 (de)
AT (1) ATE52788T1 (de)
BE (1) BE901813A (de)
DE (1) DE3577710D1 (de)
DK (1) DK80485A (de)
ES (1) ES8706719A1 (de)
FI (1) FI850759A7 (de)
GB (1) GB8404980D0 (de)
GR (1) GR850486B (de)
IT (1) IT1184890B (de)
LU (1) LU85786A1 (de)
NO (1) NO160851C (de)
PT (1) PT80008B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2416138A (en) * 2004-07-15 2006-01-18 Stegram Pharmaceuticals Ltd Chromatographic separation of trilostane mixture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1123770A (en) * 1966-11-15 1968-08-14 Sterling Drug Inc 2-cyano-3-oxo-steroids
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates

Also Published As

Publication number Publication date
FI850759A0 (fi) 1985-02-25
GR850486B (de) 1985-06-26
NO850753L (no) 1985-08-26
ES8706719A1 (es) 1987-06-16
NO160851C (no) 1989-06-07
DK80485A (da) 1985-08-26
FI850759A7 (fi) 1985-08-26
IT8567191A0 (it) 1985-02-25
PT80008B (en) 1987-01-13
ES540686A0 (es) 1987-06-16
EP0154476A3 (en) 1986-05-14
GB8404980D0 (en) 1984-03-28
BE901813A (fr) 1985-08-26
ATE52788T1 (de) 1990-06-15
IT8567191A1 (it) 1986-08-25
EP0154476A2 (de) 1985-09-11
LU85786A1 (fr) 1985-12-11
PT80008A (en) 1985-03-01
DK80485D0 (da) 1985-02-22
NO160851B (no) 1989-02-27
EP0154476B1 (de) 1990-05-16
IT1184890B (it) 1987-10-28
DE3577710D1 (de) 1990-06-21

Similar Documents

Publication Publication Date Title
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
ZA881726B (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6-carbozamides
ZA889372B (en) Cyclopropane derivatives
DK421586A (da) Irreversible dopamin-beta-hydroxylaseinhibitorer
FI850759A0 (fi) Steroidfoerening.
DE69006452D1 (de) Derivate und Analoge von Pyrimidon zur Behandlung von Asthma und bestimmte Hautkrankheiten.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
FI910059A0 (fi) Kemiska foereningar.
SE8506015D0 (sv) Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
PT82071B (pt) Processo para a preparacao de derivados de homocisteina tiolactona
EP0160521A3 (de) Komplex aus Fibronectin-Dextran und Medikament und Verfahren zu deren Herstellung
NO147232C (no) Fremgangsmaate for aa forbedre den biologiske taalbarhet av polyamidimplanteringsproteser
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
SU1282506A1 (ru) 2-(3',4',5'-триметоксифенил)-1-метилимидазо (4,5-с)пиридингидрохлорид, обладающий спазмолитической и гипотензивной активностью
DE68908020D1 (de) Entzuendungshemmendes mittel zur behandlung der krankhaften prostataerweiterung, ein verfahren fuer seine herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
DE3666808D1 (en) Acetohydroxamic-acid derivative, its preparation and therapeutical use
BG50301A1 (en) Method for treatment of verbal hallucinations
ES2020915B3 (es) Descontaminacion de aguas residuales de la fabricacion de ditiocarbamato.
DE3379224D1 (en) 3-methoxy-n-methylmorphinane : theophyllinacetic acid (1:2) complex, process for preparing the same and said complex for therapeutical use
ES8302008A1 (es) Un procedimiento para la preparacion de derivados de imidazo (2,1-b) tiazol.
ES8100295A3 (es) Procedimiento para preparar xantinas sustituidas

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: STERWIN AG